Cargando…

Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation

BACKGROUND: Adrenergic gene polymorphisms are associated with cardiovascular and metabolic phenotypes. We investigated the influence of adrenergic gene polymorphisms on cardiovascular risk in women with suspected myocardial ischemia. METHODS: We genotyped 628 women referred for coronary angiography...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacanowski, Michael A, Zineh, Issam, Li, Haihong, Johnson, B Delia, Cooper-DeHoff, Rhonda M, Bittner, Vera, McNamara, Dennis M, Sharaf, Barry L, Merz, C Noel Bairey, Pepine, Carl J, Johnson, Julie A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2329599/ https://www.ncbi.nlm.nih.gov/pubmed/18331634 http://dx.doi.org/10.1186/1479-5876-6-11

Ejemplares similares

Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored WISE Study
por: Smith, Steven M., et al.
Publicado: (2014)

Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study
por: Doyle, Mark, et al.
Publicado: (2011)

Brachial Artery Constriction during Brachial Artery Reactivity Testing Predicts Major Adverse Clinical Outcomes in Women with Suspected Myocardial Ischemia: Results from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
por: Sedlak, Tara L., et al.
Publicado: (2013)

TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
por: Petersen, John W., et al.
Publicado: (2014)

Bio-informatics assessment schema (BIAS) to improve myocardial perfusion image diagnostic and prognostic value: the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study
por: Doyle, Mark, et al.
Publicado: (2014)

Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study
por: Bairey Merz, C. Noel, et al.
Publicado: (2018)

Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: AlBadri, Ahmed, et al.
Publicado: (2017)

Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: Haftbaradaran, A, et al.
Publicado: (2015)

Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
por: Anderson, R. David, et al.
Publicado: (2019)

SAT-LB99 Inflammation May Mediate Coronary Artery Disease in Women With Hypothalamic Hypoestrogenemia: Findings From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: Torbati, Tina, et al.
Publicado: (2020)

Decisions Informed by Computing Entities (DICE) to improve prognostic value of myocardial perfusion imaging: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
por: Doyle, Mark, et al.
Publicado: (2012)

Does expanded artificial intelligence improve the prognostic value of myocardial perfusion imaging? A report from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)
por: Doyle, Mark, et al.
Publicado: (2013)

Number and Function of Bone-Marrow Derived Angiogenic Cells and Coronary Flow Reserve in Women without Obstructive Coronary Artery Disease: A Substudy of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
por: Mohandas, Rajesh, et al.
Publicado: (2013)

Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute‐Sponsored Women's Ischemia Syndrome Evaluation
por: Lee, Julie J., et al.
Publicado: (2019)

Tissue characterization with native T1 mapping in suspected coronary microvascular dysfunction and no obstructive coronary artery disease: results from the NHLBI-sponsored WISE study
por: Shaw, Jaime L, et al.
Publicado: (2016)

THE IMPACT OF THE COVID-19 PANDEMIC ON A MULTI-CENTER CLINICAL - ADAPTING IN REAL-TIME TO MAINTAIN TRIAL INTEGRITY
por: Dasa, Osama, et al.
Publicado: (2021)

Renal Function and Coronary Microvascular Dysfunction in Women with Symptoms/Signs of Ischemia
por: Mohandas, Rajesh, et al.
Publicado: (2015)

Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study
por: Mehta, Puja K., et al.
Publicado: (2017)

Subclinical systolic and diastolic dysfunction in women with signs and symptoms of ischemia but no obstructive coronary disease: novel insights using myocardial feature tracking in the NHLBI WISE study
por: Nelson, Michael D, et al.
Publicado: (2016)

Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
por: Herscovici, Romana, et al.
Publicado: (2018)

Depression Symptom Patterns as Predictors of Metabolic Syndrome and Cardiac Events in Symptomatic Women with Suspected Myocardial Ischemia: The Women’s Ischemia Syndrome Evaluation (WISE and WISE-CVD) Projects
por: Virzi, Nicole E., et al.
Publicado: (2022)

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)

Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)
por: Sedlak, Tara, et al.
Publicado: (2020)

Somatic Versus Cognitive Depressive Symptoms as Predictors of Coronary Artery Disease among Women with Suspected Ischemia: The Women’s Ischemia Syndrome Evaluation
por: Emami, Ashley S., et al.
Publicado: (2021)

Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration–Approved Drugs
por: Schuck, Robert N., et al.
Publicado: (2019)

Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA)
por: Taha, Yasmeen K., et al.
Publicado: (2023)

NHLBI support of systems biology
por: Qasba, Pankaj, et al.
Publicado: (2013)

Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study
por: Aldiwani, Haider, et al.
Publicado: (2020)

Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
por: Elgendy, Islam Y., et al.
Publicado: (2019)

Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction
por: Keeley, Ellen C., et al.
Publicado: (2022)

Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program
por: Giffen, Carol A., et al.
Publicado: (2017)

Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE)
por: Jones, Erika, et al.
Publicado: (2020)

Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy
por: Gerhard, Tobias, et al.
Publicado: (2012)

Oxidative Stress Is Associated With Diastolic Dysfunction in Women With Ischemia With No Obstructive Coronary Artery Disease
por: Raad, Mohamad, et al.
Publicado: (2020)

Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project
por: Siak, Jessica, et al.
Publicado: (2021)

Simple Integer Risk Score to Determine Prognosis of Patients With Hypertension and Chronic Stable Coronary Artery Disease
por: Bavry, Anthony A., et al.
Publicado: (2013)

Systolic blood pressure, heart rate, and outcomes in patients with coronary disease and heart failure
por: Elgendy, Islam Y., et al.
Publicado: (2019)

Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial
por: Dasa, Osama, et al.
Publicado: (2021)

Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
por: Zineh, Issam
Publicado: (2019)

Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) study
por: Jalnapurkar, Sawan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vahamh4bmru781v8e9u7d5re7e